Kareem Ahmed Basha
Director & Chief Scientific Officer
- 56Articles written
- 7Areas of expertise
About Kareem
Kareem Ahmed Basha is a director and the chief scientific officer of Winhycare Pharma in Hyderabad, India. He writes and reviews the division’s technical content on peptides, peptide APIs and lyophilisation.
He has nearly two decades of experience in pharmaceutical quality control and quality assurance. His career includes 11 years 8 months at Dr. Reddy’s Laboratories, as Assistant Manager QA in Visakhapatnam, Quality Assurance Manager at the company’s site in Cuernavaca, Mexico, and most recently Team Leader, External Manufacturing Quality Assurance (EMQA) in Hyderabad, where his work included qualification audits of contract manufacturing organisations, quality agreements with manufacturing partners, and review of deviations, CAPA and change controls for technology transfer products.
Earlier he was Deputy Manager Quality Assurance at Anthem Biosciences in Bengaluru (2013 to 2014) and worked in quality control and quality assurance at Biocon in Bengaluru for six years (2007 to 2013).
Areas of expertise
- Pharmaceutical quality assurance (cGMP, GLP)
- Vendor qualification and CMO audits
- Deviations, CAPA and change control
- Data integrity and LIMS
- Technology transfer
- Peptide APIs
- Peptide lyophilisation
Articles by Kareem
Winhycare Pharma · Peptide APIs
Amycretin: what it is, how it works and what studies have found
Amycretin (INN zenagamtide) explained: unimolecular GLP-1 and amylin receptor agonist, 68-residue structure, phase 1 and 2 data, and the AMAZE phase 3 status.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Amylin analogues explained: amylin receptors and the peptides that target them
Amylin analogues and amylin receptor agonists explained: amylin biology, AMY1-3 receptors, pramlintide, cagrilintide, petrelintide, eloralintide and amycretin.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
AOD-9604: what it is, how it works and what studies have found
AOD-9604 is Tyr-hGH(177-191), a 16-residue growth hormone fragment analogue. Sequence, mechanism, obesity trials, safety data and AOD-9604 vs hGH 176-191.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Aseptic fill finish explained: how sterile peptide vials are filled, closed and released
How aseptic fill finish works for peptide vials: terminal sterilisation vs aseptic, filtration, PUPSIT, Grade A/B, isolators vs RABS, media fills, CCI.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
BPC-157: what it is, how it is thought to work and what studies have found
BPC-157 evidence review: sequence, molecular weight, proposed mechanisms, the rodent studies, the three small human reports, FDA and WADA status, and synthesis.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
BPC-157 vs TB-500: how the two peptides differ in structure, evidence and regulatory status
BPC-157 vs TB-500 compared: origin, sequence, mass, proposed mechanisms, study counts by evidence level, FDA and WADA status, identity testing and storage.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Cagrilintide: what it is, how it works and what studies have found
Cagrilintide explained: long-acting lipidated amylin analogue, sequence, amylin and calcitonin receptor agonism, half-life, and REDEFINE trial findings.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
CDMO vs CMO vs CRDMO: what is the difference, and which one does a pharma buyer need?
What CMO, CDMO and CRDMO mean in pharma, how their scope differs, what GMP rules apply to every contract manufacturer, and which model a buyer needs.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
CJC-1295: what it is, how it works and what studies have found
CJC-1295 is a GHRH(1-29) analogue; with DAC it binds albumin. Sequence, molecular weight, half-life, human studies, WADA status and the no-DAC form explained.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
What is a drug master file? DMF, ASMF and CEP for a peptide API, with the CTD Module 3 sections
What DMF stands for, how a Type II DMF works for a peptide API, CTD Module 3 section 3.2.S, GDUFA completeness assessment, LOAs, ASMF and CEP.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Eloralintide: what it is, how it works and what studies have found
Eloralintide (LY3841136) explained: selective amylin receptor agonist structure, AMY1R selectivity, half-life, phase 1 and phase 2 data, and ENLIGHTEN phase 3.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Endotoxin testing for peptides: LAL, recombinant factor C, limits and interference
Endotoxin testing for peptides explained: how the LAL test works, LAL vs rFC vs MAT, EU/mg limits and MVD, interference, sterility and bioburden tests.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
What is EU GMP Annex 1? The 2022 sterile manufacturing rules explained, clause by clause
What EU GMP Annex 1 requires: the 2022 revision and its 2023/2024 dates, contamination control strategy, cleanroom grade tables, PUPSIT, lyophilization and APS.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
FDA-approved peptide drugs: a list by INN, approval year, target and length
FDA-approved peptide drugs listed by INN with first approval year, target and length, plus how FDA defines a peptide, 2020-2026 approvals and trends.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Generic semaglutide: EU and US regulatory pathways, and what API makers must show
How generic semaglutide is filed in the EU and US: generic vs hybrid, 8+2+1 protection, ANDA vs 505(b)(2), synthetic vs recombinant API, API maker duties.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
GLP-1 receptor agonists explained: how they work, the full list, and where research is heading
How GLP-1 receptor agonists work, a list by INN with FDA approval years, single vs dual vs triple agonists, half-life extension and research directions.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
GMP peptides explained: what GMP grade means, GLP vs GMP, and research grade vs GMP grade
What GMP grade means for a peptide API under ICH Q7, GLP vs GMP, research grade vs GMP vs pharmacopoeial grade, and when GMP material is needed.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
How to qualify a peptide API supplier: a documentation and audit checklist for EU and US buyers
A documentation and audit checklist for qualifying a peptide API supplier for EU and US filings: written confirmation, DMF/ASMF, GMP audit, impurities and agreements.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
How to read a peptide COA: every test explained, red flags and how to verify it
How to read a peptide certificate of analysis line by line: MS identity, HPLC purity, peptide content, water, TFA, solvents, endotoxin, red flags and checks.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
HPLC method validation under ICH Q2(R2) and Q14: a practical guide for peptide purity and assay methods
HPLC method validation under ICH Q2(R2) and Q14 for peptide purity and assay: specificity, range, accuracy, precision, LOD/LOQ, robustness and SST.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
What is ICH Q11? Starting materials, control strategy and Q6A/Q6B specifications for peptide drug substances
What ICH Q11 is, how starting materials and control strategy are set for synthetic peptides, where ICH Q6A and Q6B apply, and FDA and EMA peptide guidance.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
ICH Q7 explained: GMP for active pharmaceutical ingredients, chapter by chapter, with peptide APIs in focus
ICH Q7 explained for peptide APIs: scope, where GMP starts, all 20 chapters, the 2015 Q&A, how FDA and EU inspectors use it, and Q7 vs 21 CFR 211.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Linaclotide: what it is, how it works and what studies have found
Linaclotide explained: 14-residue sequence and three disulfides, GC-C and cGMP mechanism, minimal absorption, phase 3 trials, safety and disulfide synthesis.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Lyophilized (lyophilised) peptide stability and storage: how long a peptide API lasts and how to keep it
How long a lyophilized peptide API lasts, what degrades it, which storage temperatures ICH Q1A(R2) defines, how stability is tested and how to ship it safely.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Lyophilization services: how to choose a contract lyophilization CMO, and what to send them
How to choose contract lyophilization services: what to send, cycle development and scale-up, batch and vial formats, release tests and CMO questions.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Mazdutide: what it is, how it works and what studies have found
Mazdutide (IBI362, LY3305677) explained: GLP-1/glucagon dual agonist structure, sequence, half-life, GLORY and DREAMS trial data and 2025 China NMPA approvals.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Net peptide content vs HPLC purity: how amino acid analysis and mass balance measure the peptide in the vial
Net peptide content vs HPLC purity vs gross weight: amino acid analysis, nitrogen and CHN analysis, Karl Fischer water, counter-ions and stock concentrations.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Peptide API impurities and specifications: thresholds, tests and what regulators expect in 2026
How peptide API impurities are classified and controlled: why ICH Q3A does not apply, Ph. Eur. 0.1/0.5/1.0% thresholds, FDA's 2026 peptide guidance and what a specification covers.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
What is a peptide bond? Formation, structure, hydrolysis and laboratory synthesis
What a peptide bond is, how it forms by condensation, why it is planar, cis vs trans, hydrolysis, and how chemists make peptide bonds with coupling reagents.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Shipping peptides in the cold chain: packaging, dry-ice rules, receiving checks, excursions and long-term storage
Shipping peptides: lyophilized vs solution, gel packs, dry ice, data loggers, IATA dry-ice rules, receiving checks, excursions and −80 °C storage.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Peptide counter-ions: TFA vs acetate vs hydrochloride, and why the salt form changes your results
Why TFA stays on synthetic peptides, how counter-ions change assays and cells, how to exchange them, and what the salt form does to net peptide content.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
How do peptides degrade? Degradation pathways, warning signs and stability testing
How peptides degrade: deamidation, Asp isomerisation, oxidation, disulfide scrambling, hydrolysis, DKP, pyroglutamate, aggregation and forced degradation.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Peptide lyophilization (lyophilisation): a practical guide to freeze-drying peptide APIs
How peptide lyophilization (freeze-drying) works: freezing, primary and secondary drying, Tg′ and collapse temperature, excipients, cycles and vials.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Peptide mass spectrometry: how ESI, MALDI, MS/MS and LC-MS confirm a peptide's identity
Peptide mass spectrometry explained: ESI vs MALDI, charge states, monoisotopic vs average mass, b/y ions, CID/HCD/ETD, peptide mapping and LC-MS reports.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Peptide modifications for stability and half-life: lipidation, PEGylation, Aib, cyclisation and fusion
How peptides are engineered for half-life and stability: fatty acid acylation, PEGylation, Aib, D-amino acids, cyclisation, stapling and albumin binding.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Peptide purification: preparative HPLC, ion exchange and the yield versus purity trade-off
How peptides are purified: preparative RP-HPLC, ion exchange, mixed-mode, MCSGP, the yield-purity trade-off, salt exchange and lyophilization of the pool.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Peptide purity testing: how HPLC, mass spectrometry and amino acid analysis work together
How peptide purity is tested: RP-HPLC columns, TFA vs formic acid, 214 nm detection, LC-MS identity, net peptide content, amino acid analysis and ICH Q2(R2).
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Peptide synthesis: how peptides are made, from the first resin bead to a purified kilogram
How peptide synthesis works: the Fmoc SPPS cycle, LPPS, fragment condensation, recombinant and enzymatic routes, scale-up, purification, cost drivers and PMI.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
How to reconstitute lyophilized peptides in the lab: solvent choice, stock solutions, storage and troubleshooting
Peptide reconstitution for in-vitro work: pick a solvent from the sequence, make a molar assay stock, aliquot, store, and fix peptides that won't dissolve.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Retatrutide: what it is, how it works and what studies have found
Retatrutide explained: triple GIP, GLP-1 and glucagon receptor agonist, sequence and C20 di-acid, 6-day half-life, phase 2 and TRIUMPH phase 3 findings.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Retatrutide vs tirzepatide: how the triple and dual agonists compare
Retatrutide vs tirzepatide: triple vs dual agonism, sequence and linker differences, TRIUMPH vs SURMOUNT and SURPASS results side by side, safety and status.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Semaglutide: what it is, how it works and what studies have found
Semaglutide explained: sequence, C18 fatty di-acid side chain, GLP-1 receptor mechanism, one-week half-life, and the SUSTAIN, STEP and SELECT findings.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
How to read a semaglutide API certificate of analysis (COA)
A test-by-test guide to a semaglutide API COA: identity, assay, purity, peptide content, water, acetate, residual solvents, endotoxin and the specs behind them.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Semaglutide patent expiry by country: dates, status and what it means for API buyers
When semaglutide's compound protection ends in India, China, Canada, Brazil, the US, EU, UK and Japan, with primary sources, and what it means for API buyers.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Semaglutide vs tirzepatide vs liraglutide: how the three peptide APIs compare
How semaglutide, tirzepatide and liraglutide APIs differ: backbone, length, lipid chain, receptors, half-life basis, molecular weight, CAS and approval.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Sermorelin: what it is, how it works and what studies have found
Sermorelin is GHRH(1-29) amide, a 29-residue GHRH analogue. Sequence, molecular weight, GHRH receptor mechanism, FDA history, studies and comparisons.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
SPPS vs LPPS vs hybrid: how peptide APIs are manufactured, and why the route matters to buyers
Solid-phase, liquid-phase and hybrid peptide synthesis compared for API buyers: chemistry, length limits, impurities, scale, solvent use and regulatory impact.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Survodutide: what it is, how it works and what studies have found
Survodutide (BI 456906) explained: glucagon/GLP-1 dual agonist structure, sequence, mechanism, phase 2 and SYNCHRONIZE phase 3 data, MASH studies and status.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
TB-500: what it is, how it works and what studies have found
TB-500 explained: the Ac-LKKTETQ fragment vs full thymosin beta-4, actin biology, metabolism, published thymosin beta-4 trials, FDA and WADA status.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Teduglutide: what it is, how it works and what studies have found
Teduglutide explained: the [Gly2] GLP-2 analogue sequence, GLP-2 receptor biology, half-life, the STEPS trials, safety warnings and regulatory approvals.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Tesamorelin: what it is, how it works and what studies have found
Tesamorelin is a 44-residue GHRH analogue with an N-terminal trans-3-hexenoyl group. Structure, half-life, phase 3 trials, NAFLD research and FDA status.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
Tirzepatide: what it is, how it works and what studies have found
Tirzepatide explained: GIP-based sequence, C20 di-acid, dual GIP and GLP-1 receptor mechanism, 5-day half-life, and SURPASS and SURMOUNT trial findings.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
What is a lyophilized peptide? Freeze-drying explained, from the three stages to the finished cake
What lyophilized means, the three stages of freeze-drying, lyophilized vs liquid peptides, what a good cake looks like and how GMP sites make them.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
What is a peptide? Definition, types, functions and how peptides are made
What a peptide is, how it differs from a protein, dipeptides to polypeptides, what peptides do in the body, how they are made, and what research use only means.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
What is a peptide API? API vs drug substance explained
A peptide API is the active ingredient of a peptide medicine. How ICH, FDA and EU law define API, drug substance and active substance, and where peptides fit.
Kareem Ahmed Basha
Winhycare Pharma · Peptide APIs
What is WHO-GMP certification? Who issues it, what it covers and how buyers verify it
What WHO-GMP certification means: WHO GMP texts, the Certification Scheme and COPP, who issues it in India, Schedule M, prequalification, verification.
Kareem Ahmed Basha